Significant initiatives have been undertaken in the past few years to synthesize coumarins owing to their extremely reactive character and attraction as an antecedent of natural products and pharmaceutical drugs. Numerous novel multicomponent one-pot, serial combinatorial Responses have been developed, beginning with the Knoevenagel, Perkin, and Pechmann reactions. The branch of organic synthesis has advanced to a remarkable level in this century with regard to green chemistry and synthetic efficiency perspective since the advent of nontraditional energy sources, including microwaves and ultrasonic irradiation. In light of this, a lot of emphasis has been put on creating bioactive coumarin-heterocycles by novel approaches, and an array of synthetic processes have been developed. Therefore, it is crucial to regularly assess the synthesis and biological characteristics of these hybrid compounds. By using microwaves and ultrasound-aided techniques, the current review aims to highlight recent developments in the synthesis of coumarins that are fused or connected to a number of bioactive heterocycles with five or six members. A dynamic scaffold with outstanding biological potential, coumarin has been instrumental in the medical field. Heterocyclic compounds with a benzopyran-2-one ring depict numerous biological properties, inorporating antioxidant, antibacterial, anti-inflammatory, anti-cancer, anti-tubercular, as well as antithrombotic activities. The most recent developments in the medical significance of coumarin derivatives is discussed in this review. Additionally, It also analyzes the role of coumarins as fluorescence sensors of the biological system.
Two novel homologous series of target moieties, pyrazolo[3,4-b]pyridine-5-carboxylate substitutes (4a-e) as well as pyrazolo[3,4-b]pyridine-5-carbonitrile substitutes (5a-g) involving heterocyclic scaffold have been synthesized and characterized using FT-IR, NMR and MS spectrometry to ascertain the molecular structure. The synthetic procedure has been carried out by a one-pot three-constituent mechanistic pathway of pyrazol-3-amine, several aromatic aldehydes as well as selected CH-active compounds under green conditions via one-pot process in the presence of glucose coated nano Fe3O4 (Glu@Fe3O4) as an organocatalyst and ethanol as an efficient solvent. This conversion is congenial with a wide heterogeneity of functional group endurance. The optimized reaction conditions, good output, incorporation of organocatalyst, no necessity for column chromatographic procedure, economical and eco-friendly solvent are the merits of this reaction protocol. An ecofriendly, harmless, diversified, excellent paramagnetic behaviour possessing catalyst (Glu@Fe3O4) was prepared and characterization was performed incorporating Fourier transform infrared spectroscopy, as well as X-ray diffraction technique. The surface of magnetic nanoparticles enveloped with glucose imparted magnificent catalytic property. The catalyst could be reprocessed and reutilized until six rounds unaccompanied by major downfall in the catalytic efficiency.
Benzofuran derivatives are one of the main groups of biologically relevant heterocycles found in nature. Several benzofurans possess a broad spectrum of therapeutic properties, which implies that this class of chemicals is unambiguously fascinating. Owing to their potent biological attributes along with their applications as pharmacological agents, benzofuran and its analogues have attracted medicinal chemists and pharmacologists. Owing to the extensive array of biological features of benzofurans, medicinal chemists have become intrigued in their structure-activity interactions. Consequently, target molecules in several illness circumstances have been identified. Its significance for medicinal chemistry research is demonstrated by the remarkable production of benzofuran derivatives to treat a broad range of ailments in a relatively short span of time. The current review describes the various synthetic strategies and the pharmacological potential possessed by the Benzofuran nucleus.